Immix Biopharma, Inc. - Common Stock, par value $0.0001 per share (IMMX)

CUSIP: 45258H106

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
53,060,943
Total 13F shares
4,429,414
Share change
-217,472
Total reported value
$8,774,511
Price per share
$1.98
Number of holders
29
Value change
-$597,024
Number of buys
10
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 45258H106?
CUSIP 45258H106 identifies IMMX - Immix Biopharma, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IMMX - Immix Biopharma, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
AIGH Capital Management LLC
13F
Company
2.9%
1,555,000
$4,773,850 31 Mar 2024
13F
Vladimir P. Torchilin
3/4/5
Scientific Co-Founder
class O/S missing
905,200
$4,230,905 20 Dec 2021
Sean Senn
3/4/5
Under 10% owner
class O/S missing
899,800
$4,205,665 14 Jul 2022
Bleichroeder LP
13F
Company
1.6%
850,000
$2,609,500 31 Mar 2024
13F
Cable Car Capital, LP
13F
Company
1.3%
670,458
$2,058,306 31 Mar 2024
13F
VANGUARD GROUP INC
13F
Company
0.86%
456,186
$1,400,491 31 Mar 2024
13F
Lynwood Capital Management Inc.
13F
Company
0.76%
405,000
$1,243,350 31 Mar 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.5%
265,500
$815,000 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.24%
124,770
$383,105 31 Mar 2024
13F
Private Advisor Group, LLC
13F
Company
0.19%
98,775
$303,241 31 Mar 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.14%
76,901
$236,086 31 Mar 2024
13F
CORSAIR CAPITAL MANAGEMENT, L.P.
13F
Company
0.13%
69,385
$213,012 31 Mar 2024
13F
TRITONPOINT WEALTH, LLC
13F
Company
0.05%
24,526
$169,720 31 Mar 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.1%
54,281
$166,643 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
0.1%
54,045
$165,918 31 Mar 2024
13F
XTX Topco Ltd
13F
Company
0.1%
52,197
$160,245 31 Mar 2024
13F
STATE STREET CORP
13F
Company
0.08%
42,960
$131,887 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
0.07%
38,914
$119,466 31 Mar 2024
13F
TOCQUEVILLE ASSET MANAGEMENT L.P.
13F
Company
0.07%
37,800
$116,046 31 Mar 2024
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.05%
26,080
$80,000 31 Mar 2024
13F
FNY Investment Advisers, LLC
13F
Company
0.05%
25,500
$78,000 31 Mar 2024
13F
Imprint Wealth LLC
13F
Company
0.05%
26,214
$76,545 31 Mar 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.05%
24,528
$75,301 31 Mar 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.04%
22,862
$70,186 31 Mar 2024
13F
Walleye Capital LLC
13F
Company
0.04%
21,926
$67,313 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
0.04%
19,321
$59,316 31 Mar 2024
13F
InterOcean Capital Group, LLC
13F
Company
0.02%
11,900
$36,533 31 Mar 2024
13F
OLD NATIONAL BANCORP /IN/
13F
Company
0.02%
10,000
$30,700 31 Mar 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.02%
9,039
$27,750 31 Mar 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
5,696
$17,487 31 Mar 2024
13F
UBS Group AG
13F
Company
0.01%
5,258
$16,142 31 Mar 2024
13F
Steward Partners Investment Advisory, LLC
13F
Company
0%
1,492
$4,580 31 Mar 2024
13F
Tortoise Investment Management, LLC
13F
Company
0%
1,300
$3,991 31 Mar 2024
13F
Qube Research & Technologies Ltd
13F
Company
0%
1,243
$3,816 31 Mar 2024
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
434
$1,332 31 Mar 2024
13F
SIMPLEX TRADING, LLC
13F
Company
0%
509
$1,000 31 Mar 2024
13F

Institutional Holders of Immix Biopharma, Inc. - Common Stock, par value $0.0001 per share (IMMX) as of Q2 2024

As of 30 Jun 2024, Immix Biopharma, Inc. - Common Stock, par value $0.0001 per share (IMMX) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,429,414 shares. The largest 10 holders included AIGH Capital Management LLC, Bleichroeder LP, Cable Car Capital LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, Private Advisor Group, LLC, MORGAN STANLEY, STATE STREET CORP, and NORTHERN TRUST CORP. This page lists 29 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
34
Q2 2024 holders
29
Holder diff
-5
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .